A newly identified mechanism lends credence to the idea that MS may be treatable by targeting EBV-infected B-cells, a study found.

After B cells encounter an antigen, a special environment called the germinal center forms around them in the lymph nodes, in which they cycle between two zones: In one zone, called the dark zone, B ...